OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A real-world pharmacovigilance study using disproportionality analysis of united states food and drug administration adverse event reporting system events for vinca alkaloids: comparing vinorelbine and Vincristine
Cheng Zhong, Qi Zheng, Bin Zhao, et al.
Expert Opinion on Drug Safety (2024)
Closed Access | Times Cited: 6
Cheng Zhong, Qi Zheng, Bin Zhao, et al.
Expert Opinion on Drug Safety (2024)
Closed Access | Times Cited: 6
Showing 6 citing articles:
Post-marketing safety evaluation of Vortioxetine: A decade-long pharmacovigilance study based on the FAERS database
Jianhong Wu, Na Li, Jun Gu, et al.
Journal of Affective Disorders (2025)
Closed Access | Times Cited: 2
Jianhong Wu, Na Li, Jun Gu, et al.
Journal of Affective Disorders (2025)
Closed Access | Times Cited: 2
Adverse event signal analysis of remimazolam using the FDA adverse event reporting system database
Hongtao Liu, Zhaoyu Li, Su Yan, et al.
Acta Anaesthesiologica Scandinavica (2025) Vol. 69, Iss. 3
Closed Access | Times Cited: 1
Hongtao Liu, Zhaoyu Li, Su Yan, et al.
Acta Anaesthesiologica Scandinavica (2025) Vol. 69, Iss. 3
Closed Access | Times Cited: 1
Safety evaluation of ILaris: a real-world analysis of adverse events based on the FAERS Database
Xun Yi, S. L. Wu, He He, et al.
Expert Opinion on Drug Safety (2025), pp. 1-13
Closed Access | Times Cited: 1
Xun Yi, S. L. Wu, He He, et al.
Expert Opinion on Drug Safety (2025), pp. 1-13
Closed Access | Times Cited: 1
A Real‐World Disproportionality Analysis of Histamine H2‐Receptors Antagonists (Famotidine): A Pharmacovigilance Study Based on Spontaneous Reports in the FDA Adverse Event Reporting System
Dongdong Zhang, Ying Cai, Yixin Sun, et al.
Drug Development Research (2025) Vol. 86, Iss. 1
Closed Access
Dongdong Zhang, Ying Cai, Yixin Sun, et al.
Drug Development Research (2025) Vol. 86, Iss. 1
Closed Access
A real-world disproportionality analysis of ripretinib data mining of the public version of FDA adverse event reporting system
Yang Feng, Xin Fa, Yifei Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Yang Feng, Xin Fa, Yifei Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Postmarketing Safety Surveillance of Topiramate: A Signal Detection and Analysis Study Based on the FDA Adverse Event Reporting System Database
Kai Lin, Mengjiao He, Zuoqi Ding
Journal of Evidence-Based Medicine (2024) Vol. 17, Iss. 4, pp. 795-807
Closed Access
Kai Lin, Mengjiao He, Zuoqi Ding
Journal of Evidence-Based Medicine (2024) Vol. 17, Iss. 4, pp. 795-807
Closed Access
